Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management
Journal of Cardiovascular Development and Disease · 19.12.2025 · 13 (1) · 1
DOI: 10.3390/jcdd13010001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 19.12.2025. Verfasst von Andreea-Mădălina Varvara und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: niversity of Medicine and Pharmacy ‘Carol Davila’.
Abstract (Originalsprache)
Mediastinal radiotherapy plays a central role in the treatment of several malignancies, particularly Hodgkin lymphoma and breast cancer. However, exposure to thoracic radiation is associated with long-term cardiovascular complications, among which valvular heart disease (VHD) is increasingly recognized. Radiation-induced VHD typically presents after a latency period of 10–20 years and is characterized by progressive valve fibrosis, thickening, and calcification, most commonly affecting the left-sided valves. Management of radiation-induced VHD generally follows standard guidelines but remains challenging due to extensive calcification and coexisting radiation-related cardiac or pulmonary injury. A history of thoracic radiotherapy is associated with increased perioperative risk and may negatively impact surgical outcomes, which often alters the risk–benefit balance and favors less invasive therapeutic approaches. Advances in the transcatheter approach have expanded treatment options for this high-risk population; however, data on long-term outcomes remain limited. Evolving dose-reduction techniques, such as deep-inspiration breath-hold, intensity-modulated radiotherapy, and proton therapy, together with predictive dosimetric models, aim to minimize future cardiac toxicity. Given the delayed onset and progressive nature of radiation-associated VHD, structured long-term surveillance is essential to enable early detection and timely intervention in cancer survivors at risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
- Cardiology Department, Emergency Institute for Cardiovascular Diseases, 258 Fundeni Street, 022328 Bucharest, Romania.
ORCID-Profile: Andreea-Mădălina Varvara, Cătălina Andreea Parasca, Vlad Anton Iliescu, Ruxandra Oana Jurcuț
Förderung
- niversity of Medicine and Pharmacy ‘Carol Davila’
Zitieren
APA
Varvara, A. M., Parasca, C. A., Iliescu, V. A., & Jurcuț, R. O. (2025). Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management. Journal of Cardiovascular Development and Disease, 13(1), 1. https://doi.org/10.3390/jcdd13010001
Vancouver
Varvara AM, Parasca CA, Iliescu VA, Jurcuț RO. Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management. Journal of Cardiovascular Development and Disease. 2025;13(1):1. doi:10.3390/jcdd13010001
BibTeX
@article{Varvara2025,
author = {Varvara, Andreea-Mădălina and Parasca, Cătălina Andreea and Iliescu, Vlad Anton and Jurcuț, Ruxandra Oana},
title = {Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management},
journal = {Journal of Cardiovascular Development and Disease},
year = {2025},
volume = {13},
number = {1},
pages = {1},
doi = {10.3390/jcdd13010001}
}
EUVIMED